## CPT: Camden Property Trust - XLRE: Real Estate

### Executive Summary

No thesis match: MRS_20 2.3% below STRENGTH zone (4.0-10.0%); PEG 8.96 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-1.6% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($105.85)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 2
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Camden Stock Rallies 7.3% in Three Months: Will It Continue to Gain?**
- Source: TradingView â€” Track All Markets | 20260105T130755 | Bullish | Relevance: 100%
- Camden Property Trust (CPT) has seen its stock rally 7.3% in the last three months, outperforming the industry. This growth is attributed to strong renter demand in high-growth U.S. markets, diversification across urban and suburban properties, and strategic use of technology for margin expansion. The company also benefits from a healthy balance sheet and a strong development pipeline, despite concerns about apartment supply in certain markets and high interest expenses.

**2. Camden Stock Rallies 7.3% in Three Months: Will It Continue to Gain?**
- Source: Finviz | 20260105T180757 | Bullish | Relevance: 100%
- Camden Property Trust (CPT) has seen its stock rally 7.3% over the past three months, outperforming its industry. The company is well-positioned for continued growth due to strong renter demand in high-growth markets, diversification efforts, and a focus on technology to drive margin expansion. While risks like elevated apartment supply and high interest expenses exist, Camden's healthy balance sheet and strategic initiatives are expected to fuel long-term expansion.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-18 | JP Morgan | $116 | $0 | 0% |
| 2025-12-15 | Truist Securiti | $116 | $123 | -6% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-18 | JP Morgan | up | Neutral |
| 2025-12-15 | Truist Securiti | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 2 ($0.29M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 56.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 16.0% (-0.5%)
- Blackrock Inc.: 10.8% (+3.2%)
- State Street Corpora: 7.1% (+1.5%)
- FMR, LLC: 5.1% (+17.5%)
- Viking Global Invest: 3.6% (+41.6%)

### Key Risks

1. Valuation stretched: PEG 9.0x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 8.96 signals overvaluation risk, limited margin of safety. Forward P/E 81.6x stretched relative to 17% growth. Quality metrics strong (margin 17%). Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $11.7B |
| Beta | 0.82 |
| 52W Range | $97.17 - $126.55 |
| Short Interest | 3.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 8.96 |
| Forward P/E | 81.6 |
| Current P/E | 95.8 |
| YoY Growth | 17.4% |
| EPS Direction | None |

### Technicals

MRS_20 deteriorating from 4.0% to 2.3% (-1.6% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 1.7pp (needs >4.0% for momentum thesis). MRS_5 (-1.0%) diverging from MRS_20 - short-term weakness emerging. Below SMA200 (0.99x), long-term trend not supportive. OFD pattern: -DUN (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 2.33% (CS: 67) | Neutral |
| RSI_14 | 60.1 | Neutral |
| MACD Histogram | 0.21 | Bullish |
| vs SMA20 | 1.021x | Above |
| vs SMA50 | 1.044x | Above |
| vs SMA200 | 0.990x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $109.11
- **Stop Loss:** $105.85 (3.0% risk)
- **Target:** $112.37 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 352
- **Position Value:** $38,406.72
- **Portfolio %:** 38.41%
- **Risk Dollars:** $1,150.00
- **Risk Per Trade:** 1.15%
- **Modifiers:** L1 115% | L2 100% | Combined 1.15x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite. VIX remains calm at 14.9 (8th percentile) with positive yield curve (+65bps) and healthy breadth (59.2%), though elevated put/call ratio (1.27) suggests institutional hedging despite surface calm. Focus on quality with awareness of hedging activity divergence.*

### Earnings

**Next:** 2026-02-05 (Est: $0.28)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.28 | $0.21 | -23.2% |
| 2025Q2 | $0.33 | $0.31 | -6.9% |
| 2025Q1 | $0.28 | $0.36 | +29.5% |
| 2024Q4 | $0.42 | $0.37 | -11.9% |

---
*RULE-based L3 | 2026-01-07 09:36 | MRS_20*